Public company BioSig merges with Streamex, planning to raise $1.1 billion to advance RWA tokenization development.

On July 8, BioSig Technologies, a medical device technology company listed on the NASDAQ, announced a merger with another NASDAQ-listed company, Streamex Exchange Corporation, and signed a financing agreement of up to $1.1 billion aimed at advancing RWA tokenization business development, promoting on-chain integration of the $142 trillion commodity market with a focus on gold tokenization. The company will sell $100 million in priority secured Convertible Bonds and a $1 billion equity credit facility, with the deal being co-led by Tether asset custodian Cantor Fitzgerald as the lead placement agent. Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc., specializing in on-chain tokenization of real-world assets in the commodity sector. Streamex aims to bring the commodity market on-chain and has developed a primary issuance and trading infrastructure that will fundamentally change commodity finance.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)